首页 | 本学科首页   官方微博 | 高级检索  
     

激发性CD28单抗对肿瘤患者外周血FOXP3^+Treg细胞的下调作用及意义
引用本文:杜阳阳,沈丽琴,王艳茹,刘玉华,孙杰,庄志祥,邱玉华. 激发性CD28单抗对肿瘤患者外周血FOXP3^+Treg细胞的下调作用及意义[J]. 实用肿瘤学杂志, 2009, 23(2): 113-117
作者姓名:杜阳阳  沈丽琴  王艳茹  刘玉华  孙杰  庄志祥  邱玉华
作者单位:苏州大学附属第二医院肿瘤科,苏州,215004
摘    要:目的探究肿瘤患者外周血单个核细胞(PBMC)中FOXP3^+Treg经CD28单抗激发后的改变及意义。方法采用腹水诱生法及免疫亲和层析法进行单抗的制备和纯化,Ficoll密度梯度离心法获取外周血PBMC,经激发性CD28单抗10μg/mL共培养后经免疫荧光及流式细胞术分析其中FOXP3^+Treg的表达以及FOXP3^+Fas^+Treg和FOXP3^+FasL^+Treg的表达。结果免疫荧光和流式细胞术显示肿瘤患者外周血中FOXP3^+Treg表达比例为(6.208±2.754)%,而对照组为(2.653±0.638)%。FOXP3^+FasL^+Treg细胞经CD28单抗活化后FasL表达上调为(7.252±2.23)%,而健康对照组为(7.96±2.938)%,FOXP3^+Fas^+Treg活化前后的比例分别为(1.467±0.590)%和(3.692±1.822)%。结论肿瘤患者外周血中PBMC经CD28单抗激发后FOXP3^+Treg的比例下调(P〈0.01),提示该抗体能够使肿瘤患者的免疫功能得到一定程度的恢复与提高。

关 键 词:FOXP3^+Treg  PBMC  Fas/FasL  CD28单抗

The role and significance of CD28 monoclonal antibody stimulating peripheral blood of patients with tumors of FOXP3+Treg cells
DU Yangyang,Shen Liqin,WANG Yanru,LIU Yuhua,SUN Jie,ZHUANG Zhixiang,QIU Yuhua. The role and significance of CD28 monoclonal antibody stimulating peripheral blood of patients with tumors of FOXP3+Treg cells[J]. Journal of Practical Oncology, 2009, 23(2): 113-117
Authors:DU Yangyang  Shen Liqin  WANG Yanru  LIU Yuhua  SUN Jie  ZHUANG Zhixiang  QIU Yuhua
Affiliation:( Suzhou University Medical Biotechnology Research Institute, Suzhou 215007)
Abstract:Objective To explore the change and significance of FOXP3^+ Treg within peripheral blood mononudear cells(PBMC) ,which stimulated by CD28 monoelonal antibody in tumor patients. Methods Ascites induced immune and pro - law chromatography for purification and preparation of the monoclonal antibody, Ficoll density gradient centrifugation to obtain peripheral blood PBMC, and/or stimulated by CD28 monoclonal antibody 10 μg/mL after co -culture by immunofluorescence and flow eytometry analysis of FOXP3^+ Treg, as well as the expression of FOXP3^+ Fas^+ Treg and FOXP3^+ FasL^+ Treg. Results Immunofluorescenee and flow eytometry showed that the peripheral blood of tumor patients with FOXP3^+ Treg expression ratio(6. 208±2.754)% ,while the control group (2.653 ± 0.638 )%. FOXP3^+ FasL^+ Treg cells activated by CD28 monoelonal antibody for the FasL expression(7.252 ± 2.23 )%, and healthy control group( 7.96 ± 2.938 )% Before and after activation the ratio of FOXP3^+Fas^+Treg(1.467 ± 0.590)% ,(3.692 ± 1. 822)%. Conclusion The ratio of FOXP3^+Treg within PBMC in tumor patients decreased(P 〈 0.01 )after stimulating by CD28 monoclonal antibody which suggested the patients immune function recover and improve.
Keywords:FOXP3 Treg  PBMC  Fas/FasL
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号